Breaking News

Trump Media & Technology Group Sends Correspondence to Nasdaq regarding ‘Naked’ Short Selling Inquiries Unexpected Health Benefits of Ozempic and Mounjaro London’s National Theatre to Debut Stage Adaptation of Ballet Shoes Francois Hardy Named Chief Technology Officer of Newmont (NYSE:NEM) Jaromír Jágr makes history as oldest professional hockey player by scoring in first game since turning 52, surpassing Gordie Howe

More than 6 million Americans are living with heart failure, while the global number of people with heart failure and reduced ejection fraction is over 11 million, as reported in a 2020 study by the American Medical Association. In recent years, advancements in medical technology have led to the development of new tools to help detect heart failure early on.

One such tool is an AI-enhanced stethoscope developed by the Mayo Clinic and Eko Health. This innovative device has been recently FDA-cleared to help detect heart failure in just seconds. The traditional stethoscope, which has been in use since 1816, has received an AI makeover. Doctors rely on the stethoscope to listen to a patient’s heart and lungs to make diagnostic assessments. However, sometimes further tests such as CT or MRI scans are required for a definitive diagnosis. Additionally, an electrocardiogram (ECG) is used to measure the heart’s electrical activity.

Connor Landgraf, CEO of Eko Health, has a personal and professional interest in using AI to enhance medical care. He explains that his family’s history of pulmonary disease motivated him to explore better technologies for identifying early signs of illness. The AI program developed by Mayo Clinic and Eko Health was trained on recordings from over 100,000 patients to interpret heart activity, allowing it to quickly assess a person’s heart strength and detect early signs of heart failure with low ejection fraction in just seconds.

Dr. Paul Friedman, a cardiologist at Mayo Clinic, emphasizes the importance of early detection for heart failure, which can lead to serious complications if left untreated. The AI-enhanced stethoscope is now available for $429 with a monthly subscription and represents a breakthrough technology that can help identify heart issues that might otherwise go undetected.

In conclusion, the development of new tools like the AI-enhanced stethoscope represents significant progress in the field of medical technology and could lead to improved outcomes for patients with heart failure. With more than 6 million Americans living with this condition and millions more worldwide, it is crucial that we continue exploring ways to improve early detection and treatment options.

Leave a Reply